EVLO - Evelo Biosciences, Inc. - SEC Form 4 Insider Trading Screener
2 results - 
- 
- 
- 
- 
- 
- 
- - - - - - | TC | cnt | 1d | 1w | 1m | 6m |
X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Insider Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2018-05-11 | EVLO | Flagship Ventures Fund IV General Partner LLC | 10% | P - Purchase | $16.00 | +281,250 | 18,233,403 | +2% | +$4,500,000 | |||||
| D | 2018-05-11 | EVLO | Flagship Ventures Fund V General Partner LLC | 10% | P - Purchase | $16.00 | +281,250 | 18,233,403 | +2% | +$4,500,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |